Newsbenzinga
Envoy Medical Submits First Module Of Modular Premarket Approval Application To FDA For Breakthrough Device-Designated Product; Co Plans Four Module Submissions, Final Data Filing Targeted Q2 2027
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…